AAAAAA

   
Results: 1-16 |
Results: 16
HYPOXIA AND CYP1A1 INDUCTION-DEPENDENT REGULATION OF PROTEINS INVOLVED IN GLUCOSE-UTILIZATION IN CACO-2 CELLS
Authors: CARRIERE V RODOLOSSE A LACASA M CAMBIER D ZWEIBAUM A ROUSSET M
Citation: V. Carriere et al., HYPOXIA AND CYP1A1 INDUCTION-DEPENDENT REGULATION OF PROTEINS INVOLVED IN GLUCOSE-UTILIZATION IN CACO-2 CELLS, American journal of physiology: Gastrointestinal and liver physiology, 37(6), 1998, pp. 1101-1108
GALNAC-ALPHA-O-BENZYL INHIBITS NEUAC-ALPHA-2-3 GLYCOSYLATION AND BLOCKS THE INTRACELLULAR-TRANSPORT OF APICAL GLYCOPROTEINS AND MUCUS IN DIFFERENTIATED HT-29 CELLS
Authors: HUET G HENNEBICQREIG S DEBOLOS C ULLOA F LESUFFLEUR T BARBAT A CARRIERE V KIM I REAL FX DELANNOY P ZWEIBAUM A
Citation: G. Huet et al., GALNAC-ALPHA-O-BENZYL INHIBITS NEUAC-ALPHA-2-3 GLYCOSYLATION AND BLOCKS THE INTRACELLULAR-TRANSPORT OF APICAL GLYCOPROTEINS AND MUCUS IN DIFFERENTIATED HT-29 CELLS, The Journal of cell biology, 141(6), 1998, pp. 1311-1322
TRYPANOSOMA-CRUZI - IMPACT OF CLONAL EVOLUTION OF THE PARASITE ON ITSBIOLOGICAL AND MEDICAL PROPERTIES
Authors: REVOLLO S OURY B LAURENT JP BARNABE C QUESNEY V CARRIERE V NOEL S TIBAYRENC M
Citation: S. Revollo et al., TRYPANOSOMA-CRUZI - IMPACT OF CLONAL EVOLUTION OF THE PARASITE ON ITSBIOLOGICAL AND MEDICAL PROPERTIES, Experimental parasitology, 89(1), 1998, pp. 30-39
DECREASED EXPRESSION OF GAMMA-GLUTAMYL-TRANSPEPTIDASE IN THE INTESTINAL-CELL LINE CACO-2 BY INDUCERS OF CYTOCHROME-P450 1A1
Authors: CARRIERE V DUSSAULX E ROUSSET M ZWEIBAUM A CAMBIER D
Citation: V. Carriere et al., DECREASED EXPRESSION OF GAMMA-GLUTAMYL-TRANSPEPTIDASE IN THE INTESTINAL-CELL LINE CACO-2 BY INDUCERS OF CYTOCHROME-P450 1A1, Biochemical pharmacology, 56(7), 1998, pp. 817-823
GLUCOSE-DEPENDENT TRANSCRIPTIONAL REGULATION OF THE HUMAN SUCROSE-ISOMALTASE (SI) GENE
Authors: RODOLOSSE A CARRIERE V CHANTRET I LACASA M ZWEIBAUM A ROUSSET M
Citation: A. Rodolosse et al., GLUCOSE-DEPENDENT TRANSCRIPTIONAL REGULATION OF THE HUMAN SUCROSE-ISOMALTASE (SI) GENE, Biochimie, 79(2-3), 1997, pp. 119-123
CYP3A5 IS THE MAJOR CYTOCHROME-P450 3A EXPRESSED IN HUMAN COLON AND COLONIC CELL-LINES
Authors: GERVOT L CARRIERE V COSTET P CUGNENC PH BERGER A BEAUNE PH DEWAZIERS I
Citation: L. Gervot et al., CYP3A5 IS THE MAJOR CYTOCHROME-P450 3A EXPRESSED IN HUMAN COLON AND COLONIC CELL-LINES, Environmental toxicology and pharmacology, 2(4), 1996, pp. 381-388
HUMAN CYTOCHROME-P450 2E1 (CYP2E1) - FROM GENOTYPE TO PHENOTYPE
Authors: CARRIERE V BERTHOU F BAIRD S BELLOC C BEAUNE P DEWAZIERS I
Citation: V. Carriere et al., HUMAN CYTOCHROME-P450 2E1 (CYP2E1) - FROM GENOTYPE TO PHENOTYPE, Pharmacogenetics, 6(3), 1996, pp. 203-211
REGULATION OF SUCRASE-ISOMALTASE AND HEXOSE TRANSPORTERS IN CACO-2 CELLS - A ROLE FOR CYTOCHROME P-4501A1
Authors: CARRIERE V BARBAT A ROUSSET M BROTLAROCHE E DUSSAULX E CAMBIER D DEWAZIERS I BEAUNE P ZWEIBAUM A
Citation: V. Carriere et al., REGULATION OF SUCRASE-ISOMALTASE AND HEXOSE TRANSPORTERS IN CACO-2 CELLS - A ROLE FOR CYTOCHROME P-4501A1, American journal of physiology: Gastrointestinal and liver physiology, 33(6), 1996, pp. 976-986
A SLOW ACETYLATOR GENOTYPE IS A RISK FACTOR FOR SULFONAMIDE-INDUCED TOXIC EPIDERMAL NECROLYSIS AND STEVENS-JOHNSON SYNDROME
Authors: WOLKENSTEIN P CARRIERE V CHARUE D BASTUJIGARIN S REVUZ J ROUJEAU JC BEAUNE P BAGOT M
Citation: P. Wolkenstein et al., A SLOW ACETYLATOR GENOTYPE IS A RISK FACTOR FOR SULFONAMIDE-INDUCED TOXIC EPIDERMAL NECROLYSIS AND STEVENS-JOHNSON SYNDROME, Pharmacogenetics, 5(4), 1995, pp. 255-258
SLOW ACETYLATOR GENOTYPE AS A METABOLIC PREDISPOSITION TO SULFONAMIDE-INDUCED TOXIC EPIDERMAL NECROLYSIS
Authors: WOLKENSTEIN P CARRIERE V CHARUE D ROUJEAU JC BEAUNE P BAGOT M
Citation: P. Wolkenstein et al., SLOW ACETYLATOR GENOTYPE AS A METABOLIC PREDISPOSITION TO SULFONAMIDE-INDUCED TOXIC EPIDERMAL NECROLYSIS, Journal of investigative dermatology, 104(1), 1995, pp. 156-156
EXPRESSION OF CYTOCHROME-P-450 3A IN HT29-MTX CELLS AND CACO-2 CLONE TC7 (VOL 355, PG 247, 1994)
Authors: CARRIERE V LESUFFLEUR T BARBAT A ROUSSET M DUSSAULX E COSTET P DEWAZIERS I BEAUNE P ZWEIBAUM A
Citation: V. Carriere et al., EXPRESSION OF CYTOCHROME-P-450 3A IN HT29-MTX CELLS AND CACO-2 CLONE TC7 (VOL 355, PG 247, 1994), FEBS letters, 362(1), 1995, pp. 99-99
IMPAIRED DNA METHYLATION AND DNA ADDUCT CONCENTRATIONS IN HUMAN PERITUMORAL AND TUMORAL COLORECTAL SAMPLES AND NORMAL COLON
Authors: PFOHLLESZKOWICZ A GROSSE Y CARRIERE V CUGNENC PH BERGER A CARNOT F HUC A BEAUNE P DEWAZIERS I
Citation: A. Pfohlleszkowicz et al., IMPAIRED DNA METHYLATION AND DNA ADDUCT CONCENTRATIONS IN HUMAN PERITUMORAL AND TUMORAL COLORECTAL SAMPLES AND NORMAL COLON, Clinical chemistry, 41(12B), 1995, pp. 1924-1926
HIGH-LEVELS OF DNA-ADDUCTS IN HUMAN COLON ARE ASSOCIATED WITH COLORECTAL-CANCER
Authors: PFOHLLESZKOWICZ A GROSSE Y CARRIERE V CUGNENC PH BERGER A CARNOT F BEAUNE P DEWAZIERS I
Citation: A. Pfohlleszkowicz et al., HIGH-LEVELS OF DNA-ADDUCTS IN HUMAN COLON ARE ASSOCIATED WITH COLORECTAL-CANCER, Cancer research, 55(23), 1995, pp. 5611-5616
SLOW ACETYLATOR GENOTYPE AS A METABOLIC PREDISPOSITION TO SULFONAMIDE-INDUCED TOXIC EPIDERMAL NECROLYSIS
Authors: WOLKENSTEIN P CARRIERE V CHARUE D REVUZ J ROUJEAU JC BEAUNE P BAGOT M
Citation: P. Wolkenstein et al., SLOW ACETYLATOR GENOTYPE AS A METABOLIC PREDISPOSITION TO SULFONAMIDE-INDUCED TOXIC EPIDERMAL NECROLYSIS, Journal of investigative dermatology, 103(3), 1994, pp. 423-423
EXPRESSION OF CYTOCHROME-P-450 3A IN HT29-MTX CELLS AND CACO-2 CLONE TC7
Authors: CARRIERE V LESUFFLEUR T BARBAT A ROUSSET M DUSSAULX E COSTET P DEWAZIERS I BEAUNE P ZWEIBAUM A
Citation: V. Carriere et al., EXPRESSION OF CYTOCHROME-P-450 3A IN HT29-MTX CELLS AND CACO-2 CLONE TC7, FEBS letters, 355(3), 1994, pp. 247-250
BOTH CYTOCHROMES P450 2E1 AND 1A1 ARE INVOLVED IN THE METABOLISM OF CHLORZOXAZONE
Authors: CARRIERE V GOASDUFF T RATANASAVANH D MOREL F GAUTIER JC GUILLOUZO A BEAUNE P BERTHOU F
Citation: V. Carriere et al., BOTH CYTOCHROMES P450 2E1 AND 1A1 ARE INVOLVED IN THE METABOLISM OF CHLORZOXAZONE, Chemical research in toxicology, 6(6), 1993, pp. 852-857
Risultati: 1-16 |